Our Focus
Our primary focus in 2023 is supporting, championing and unblocking research for Chromophobe Renal Cell Carcinoma. We will also be building out and adding resources for ChRCC and other renal oncocytic tumors such as oncocytomas, SDH and others throughout the year.
ChRCC
Our mission for ChRCC is to fund research that aims to identify biological hallmarks of ChRCC to deepen learnings across institutions and to support efforts that aim to identify and test distinct therapeutic approaches. Additionally, we aim to promote collaboration, create resources for those affected by the disease and to advance the understanding of ChRCC through the dissemination of knowledge and research.